Rocket Pharmaceuticals Inc (NASDAQ: RCKT) on Friday, plunged -2.69% from the previous trading day, before settling in for the closing price of $7.43. Within the past 52 weeks, RCKT’s price has moved between $4.55 and $26.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 10.35%. With a float of $98.92 million, this company’s outstanding shares have now reached $106.45 million.
Let’s look at the performance matrix of the company that is accounted for 299 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Rocket Pharmaceuticals Inc is 7.22%, while institutional ownership is 101.88%. The most recent insider transaction that took place on Apr 22 ’25, was worth 5,139. In this transaction an insider of this company sold 718 shares at a rate of $7.16, taking the stock ownership to the 65,039 shares. Before that another transaction happened on Apr 22 ’25, when Company’s Officer proposed sale 718 for $7.16, making the entire transaction worth $5,140.
Rocket Pharmaceuticals Inc (RCKT) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 10.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 67.53% during the next five years compared to -11.60% drop over the previous five years of trading.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Rocket Pharmaceuticals Inc (RCKT) is currently performing well based on its current performance indicators. A quick ratio of 9.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.73, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -1.61 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) saw its 5-day average volume 3.25 million, a positive change from its year-to-date volume of 2.2 million. As of the previous 9 days, the stock’s Stochastic %D was 91.26%. Additionally, its Average True Range was 0.61.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 25.65%, which indicates a significant decrease from 90.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.24% in the past 14 days, which was higher than the 77.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.94, while its 200-day Moving Average is $14.27. Nevertheless, the first resistance level for the watch stands at $7.38 in the near term. At $7.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.65. If the price goes on to break the first support level at $7.11, it is likely to go to the next support level at $6.98. Assuming the price breaks the second support level, the third support level stands at $6.84.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
Market capitalization of the company is 770.93 million based on 106,630K outstanding shares. Right now, sales total 0 K and income totals -258,750 K. The company made 0 K in profit during its latest quarter, and -60,330 K in sales during its previous quarter.
